Non-Inferiority Trial
A trial designed to demonstrate that a new intervention is not worse than an active comparator by more than a pre-specified, clinically acceptable margin.
Definition
A non-inferiority trial is designed to demonstrate that a new intervention is not unacceptably worse than an active comparator. The pre-specified non-inferiority margin (delta) defines the largest difference that would still be considered clinically acceptable; a one-sided 95% confidence interval that excludes a difference worse than the margin establishes non-inferiority. Common in MedTech when a placebo or sham control would be unethical (e.g., comparing a new drug-eluting stent against an established one).What this means in practice
Margin selection is the most contested element. FDA expects the margin to be both clinically defensible and to preserve a meaningful fraction of the comparator's effect over placebo (the 'M1/M2' framework).- •Choosing a margin that's clinically defensible but doesn't preserve enough of the active comparator's effect, FDA will reject the design.
- •Running a non-inferiority trial with poor protocol adherence, drift biases toward the null and toward false NI conclusions.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsTrial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.
Single endpoint combining multiple component outcomes (e.g., MACE = death + MI + stroke).
International standard for the design, conduct, and reporting of clinical trials.
Definitive clinical study designed to establish safety and effectiveness for marketing authorization.
More in Clinical & Trials
· Same categoryAny untoward medical occurrence in a subject, whether or not related to the device.
Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available).
An IVD's ability to detect small quantities of an analyte.
Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries.
Primary references
3 sources- 1
FDA Guidance, Non-Inferiority Clinical Trials (2016)VerifiedFDAfda.gov
- 2
ICH E10 Choice of Control GroupVerifiedICHich.org
- 3
ICH GuidelinesVerifiedICHich.org
Inline markers like [1] jump to the matching reference above.